SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-010025
Filing Date
2024-02-02
Accepted
2024-02-02 16:08:49
Documents
7
Effectiveness Date
2024-02-02

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm244436d1_s8.htm S-8 76075
2 EXHIBIT 5.1 tm244436d1_ex5-1.htm EX-5.1 10062
3 EXHIBIT 23.2 tm244436d1_ex23-2.htm EX-23.2 1832
4 EX-FILING FEES tm244436d1_ex-filingfees.htm EX-FILING FEES 22740
5 GRAPHIC tm244436d1_ex5-1img001.jpg GRAPHIC 3906
6 GRAPHIC tm244436d1_ex5-1img003.jpg GRAPHIC 1084
7 GRAPHIC tm244436d1_ex5-1img002.jpg GRAPHIC 2044
  Complete submission text file 0001104659-24-010025.txt   121962
Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent Biopharma, Inc. (Filer) CIK: 0001868279 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276840 | Film No.: 24591439
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)